Illumina (ILMN) Said to Have Purchase Moleculo, Inc.

January 8, 2013 11:57 AM EST Send to a Friend
Illumina, Inc. (NASDAQ: ILMN) said it purchase Moleculo, Inc. The news comes as it filed an 8-K earlier disclosing that it withdrew its offer for Complete Genomics (Nasdaq: GNOM).

The biotech is presenting at the JPMorgan Global Healthcare Conference today. Shares are up 1.8 percent on the session.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog, Mergers and Acquisitions

Related Entities

JPMorgan

Add Your Comment